Showing results (11-20 of 96) with videos related to
Sort By:
Pageof 10
Statistics in Medicine|September 2, 2008
An efficient method for accommodating potentially underpowered primary endpointsJianjun Li, Devan V MehrotraStatistics in Medicine|April 21, 2006
Analysis of antiretroviral immunotherapy trials with potentially non-normal and incomplete longitudinal dataRobin Mogg, Devan V MehrotraStatistics in Medicine|December 19, 2009
Specification of covariance structure in longitudinal data analysis for randomized clinical trialsKaifeng Lu, Devan V MehrotraStatistics in Medicine|March 15, 2012
Flagging clinical adverse experiences: reducing false discoveries without materially compromising power for detecting true signalsDevan V Mehrotra, Adeniyi J AdewaleStatistical Methods in Medical Research|June 17, 2004
Use of the false discovery rate for evaluating clinical safety dataDevan V Mehrotra, Joseph F HeyseBiometrical Journal. Biometrische Zeitschrift|October 22, 2008
Gatekeeping testing via adaptive alpha allocationJianjun' David ' Li, Devan V MehrotraClinical Trials (London, England)|February 2, 2024
Is inadequate risk stratification diluting hazard ratio estimates in randomized clinical trials?Devan V Mehrotra, Rachel Marceau WestStatistics in Medicine|September 21, 2020
Survival analysis using a 5-step stratified testing and amalgamation routine (5-STAR) in randomized clinical trialsDevan V Mehrotra, Rachel Marceau WestStatistics in Medicine|September 10, 2011
The benefit of stratification in clinical trials revisitedJitendra Ganju, Kefei ZhouStatistics in Medicine|April 2, 2005
A method to estimate the variance of an endpoint from an on-going blinded trialBiao Xing, Jitendra GanjuPageof 10